Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Der Urologe. Ausg. A|July 23, 2002
[Immunotherapy of metastatic renal cell carcinoma in Germany. An assessment of the current status]E Huland, H Heinzer, S Timm, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1995
Toxicity of local, continuous and cyclic, high-dose bladder perfusion with recombinant and natural interleukin-2 in advanced cancer of the urinary bladderH Schwaibold, E Huland, H Heinzer, et al.The Journal of Urology|April 1, 1992
Unusual differential diagnosis of testis tumor: intrascrotal sarcoidosisA J Gross, H Heinzer, V Loy, et al.Der Urologe. Ausg. A|January 1, 1995
[Transurethral laser therapy of benign prostatic hyperplasia]S Conrad, D Gonnermann, H Heinzer, et al.Der Urologe. Ausg. A|June 5, 2004
Therapeutic approaches in metastatic renal cell carcinoma: local immunotherapyEdith Huland, H Heinzer, R A Jörres, et al.Der Urologe. Ausg. A|May 12, 2011
[Metastatic renal cell cancer in Germany in 2010. Impact of different target therapies]M Siebels, A Hegele, Z Varga, et al.Der Urologe. Ausg. A|December 18, 2008
[Role of lymph node dissection in prostate cancer]T Schlomm, C Börgermann, H Heinzer, et al.Der Urologe. Ausg. A|January 10, 1998
[Long-term results of Stamey bladder neck suspension. Effect of data analysis technique on surgical result]S Conrad, H Heinzer, S Fernandez de la Maza, et al.Der Urologe. Ausg. A|March 21, 2009
[The value of real-time elastography in the diagnosis of prostate cancer]G Salomon, M Graefen, H Heinzer, et al.Aktuelle Urologie|November 26, 2009
[Impact of immunotherapy in metastatic kidney cancer in Germany after introduction of new target therapy--results of a telephone survey of the German Society of Immuno- and Targeted Therapy (DGFIT)]M Siebels, M Staehler, A Hegele, et al.Pageof 5